{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:42:08Z","timestamp":1792806128155,"version":"4.5.0"},"reference-count":17,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>The development of transcranial MR-guided focused ultrasound (MRgFUS) has revitalized the practice of lesioning procedures in functional neurosurgery. Previous health economic analysis found MRgFUS thalamotomy to be a cost-effective treatment for patients with essential tremor, supporting its reimbursement. With the publication of level I evidence in support of MRgFUS thalamotomy for patients with tremor-dominant Parkinson\u2019s disease (TDPD), the authors performed a health economic comparison between MRgFUS, deep brain stimulation (DBS), and medical therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>The authors used a decision tree model with rollback analysis and one-factor sensitivity analysis. Literature searches of MRgFUS thalamotomy and unilateral DBS of the ventrointermediate nucleus of the thalamus for TDPD were performed to determine the utility and probabilities for the model. Costs in Canadian dollars (CAD) were derived from the Schedule of Benefits and Fees in Ontario, Canada, and expert opinion on usage.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>MRgFUS was associated with an expected cost of $14,831 CAD. Adding MRgFUS to continued medical therapy resulted in an incremental cost-effectiveness ratio of $30,078 per quality-adjusted life year (QALY), which remained cost-effective under various scenarios in the sensitivity analysis. Comparing DBS to MRgFUS, while DBS did not achieve the willingness-to-pay threshold ($56,503 per QALY) in the base case scenario, it did so under several scenarios in the sensitivity analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>MRgFUS thalamotomy is a cost-effective treatment for patients with TDPD, particularly over continued medical therapy. While MRgFUS remains competitive with DBS, the cost-effectiveness advantage is less substantial. These results will help inform the integration of this technology in the healthcare system.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3171\/2020.5.jns20692","type":"journal-article","created":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T03:43:51Z","timestamp":1596771831000},"page":"273-278","source":"Crossref","is-referenced-by-count":24,"title":["Cost-effectiveness analysis of MR-guided focused ultrasound thalamotomy for tremor-dominant Parkinson\u2019s disease"],"prefix":"10.3171","volume":"135","author":[{"given":"Ying","family":"Meng","sequence":"first","affiliation":[{"name":"Division of Neurosurgery, Sunnybrook Health Sciences Centre;"},{"name":"Harquail Centre for Neuromodulation, Sunnybrook Research Institute;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher B.","family":"Pople","sequence":"additional","affiliation":[{"name":"Division of Neurosurgery, Sunnybrook Health Sciences Centre;"},{"name":"Harquail Centre for Neuromodulation, Sunnybrook Research Institute;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suneil K.","family":"Kalia","sequence":"additional","affiliation":[{"name":"Division of Neurosurgery, Toronto Western Hospital, University Health Network;"},{"name":"Krembil Research Institute, Toronto Western Hospital, University Health Network;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine V.","family":"Kalia","sequence":"additional","affiliation":[{"name":"Krembil Research Institute, Toronto Western Hospital, University Health Network;"},{"name":"Morton and Gloria Shulman Movement Disorders Clinic and the Edmond J. Safra Program in Parkinson\u2019s Disease, Toronto Western Hospital, University Health Network; and"},{"name":"Tanz Centre for Research in Neurodegenerative Diseases, and"},{"name":"Department of Medicine, Division of Neurology, University of Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Davidson","sequence":"additional","affiliation":[{"name":"Division of Neurosurgery, Sunnybrook Health Sciences Centre;"},{"name":"Harquail Centre for Neuromodulation, Sunnybrook Research Institute;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Bigioni","sequence":"additional","affiliation":[{"name":"Division of Neurosurgery, Sunnybrook Health Sciences Centre;"},{"name":"Harquail Centre for Neuromodulation, Sunnybrook Research Institute;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Zhengze","family":"Li","sequence":"additional","affiliation":[{"name":"Division of Neurosurgery, Sunnybrook Health Sciences Centre;"},{"name":"Harquail Centre for Neuromodulation, Sunnybrook Research Institute;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suganth","family":"Suppiah","sequence":"additional","affiliation":[{"name":"Division of Neurosurgery, Sunnybrook Health Sciences Centre;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Mithani","sequence":"additional","affiliation":[{"name":"Division of Neurosurgery, Sunnybrook Health Sciences Centre;"},{"name":"Harquail Centre for Neuromodulation, Sunnybrook Research Institute;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Scantlebury","sequence":"additional","affiliation":[{"name":"Division of Neurosurgery, Sunnybrook Health Sciences Centre;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L.","family":"Schwartz","sequence":"additional","affiliation":[{"name":"Division of Neurosurgery, Sunnybrook Health Sciences Centre;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clement","family":"Hamani","sequence":"additional","affiliation":[{"name":"Division of Neurosurgery, Sunnybrook Health Sciences Centre;"},{"name":"Harquail Centre for Neuromodulation, Sunnybrook Research Institute;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nir","family":"Lipsman","sequence":"additional","affiliation":[{"name":"Division of Neurosurgery, Sunnybrook Health Sciences Centre;"},{"name":"Harquail Centre for Neuromodulation, Sunnybrook Research Institute;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"issue":"10","key":"b1","series-title":"Neurology","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1212\/WNL.40.10.1529","article-title":"Variable expression of Parkinson\u2019s disease: a base-line analysis of the DATATOP cohort","volume":"40","author":"Jankovic\n \nJ","year":"1990","unstructured":"Jankovic\n \nJ\n\n, \n\nMcDermott\n \nM\n\n, \n\nCarter\n \nJ\n\n, \n\n\n \nVariable expression of Parkinson\u2019s disease: a base-line analysis of the DATATOP cohort\n. \nNeurology\n. \n1990\n;\n40\n(\n10\n):\n1529\n\u2013\n1534\n.\n221594310.1212\/WNL.40.10.1529"},{"issue":"2","key":"b2","series-title":"Neurology","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1212\/WNL.0000000000004078","article-title":"Baseline motor findings and Parkinson disease prognostic subtypes","volume":"89","author":"Rajput\n \nAH","year":"2017","unstructured":"Rajput\n \nAH\n\n, \n\nRajput\n \nML\n\n, \n\nFerguson\n \nLW\n\n, \n\nRajput\n \nA\n\n\n. \nBaseline motor findings and Parkinson disease prognostic subtypes\n. \nNeurology\n. \n2017\n;\n89\n(\n2\n):\n138\n\u2013\n143\n.\n10.1212\/WNL.000000000000407828592451"},{"issue":"5","key":"b3","series-title":"Mov Disord","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/mds.25383","article-title":"How to identify tremor dominant and postural instability\/gait difficulty groups with the Movement Disorder Society Unified Parkinson\u2019s Disease Rating Scale: comparison with the Unified Parkinson\u2019s Disease Rating Scale","volume":"28","author":"Stebbins\n \nGT","year":"2013","unstructured":"Stebbins\n \nGT\n\n, \n\nGoetz\n \nCG\n\n, \n\nBurn\n \nDJ\n\n, \n\n\n \nHow to identify tremor dominant and postural instability\/gait difficulty groups with the Movement Disorder Society Unified Parkinson\u2019s Disease Rating Scale: comparison with the Unified Parkinson\u2019s Disease Rating Scale\n. \nMov Disord\n. \n2013\n;\n28\n(\n5\n):\n668\n\u2013\n670\n.\n10.1002\/mds.2538323408503"},{"issue":"8","key":"b4","series-title":"Mov Disord","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1002\/mds.23116","article-title":"The identification of Parkinson\u2019s disease subtypes using cluster analysis: a systematic review","volume":"25","author":"van Rooden\n \nSM","year":"2010","unstructured":"van Rooden\n \nSM\n\n, \n\nHeiser\n \nWJ\n\n, \n\nKok\n \nJN\n\n, \n\n\n \nThe identification of Parkinson\u2019s disease subtypes using cluster analysis: a systematic review\n. \nMov Disord\n. \n2010\n;\n25\n(\n8\n):\n969\n\u2013\n978\n.\n2053582310.1002\/mds.23116"},{"issue":"5","key":"b5","series-title":"J Neurol Neurosurg Psychiatry","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1136\/jnnp.71.5.682","article-title":"Long term safety and efficacy of unilateral deep brain stimulation of the thalamus for parkinsonian tremor","volume":"71","author":"Lyons\n \nKE","year":"2001","unstructured":"Lyons\n \nKE\n\n, \n\nKoller\n \nWC\n\n, \n\nWilkinson\n \nSB\n\n, \n\nPahwa\n \nR\n\n\n. \nLong term safety and efficacy of unilateral deep brain stimulation of the thalamus for parkinsonian tremor\n. \nJ Neurol Neurosurg Psychiatry\n. \n2001\n;\n71\n(\n5\n):\n682\n\u2013\n684\n.\n10.1136\/jnnp.71.5.68211606685"},{"issue":"1","key":"b6","series-title":"AJR Am J Roentgenol","doi-asserted-by":"publisher","first-page":"150","DOI":"10.2214\/AJR.14.13632","article-title":"Transcranial MRI-guided focused ultrasound: a review of the technologic and neurologic applications","volume":"205","author":"Ghanouni\n \nP","year":"2015","unstructured":"Ghanouni\n \nP\n\n, \n\nPauly\n \nKB\n\n, \n\nElias\n \nWJ\n\n, \n\n\n \nTranscranial MRI-guided focused ultrasound: a review of the technologic and neurologic applications\n. \nAJR Am J Roentgenol\n. \n2015\n;\n205\n(\n1\n):\n150\n\u2013\n159\n.\n2610239410.2214\/AJR.14.13632"},{"issue":"12","key":"b7","series-title":"JAMA Neurol","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1001\/jamaneurol.2017.3098","article-title":"Safety and efficacy of focused ultrasound thalamotomy for patients with medication-refractory, tremor-dominant Parkinson disease: a randomized clinical trial","volume":"74","author":"Bond\n \nAE","year":"2017","unstructured":"Bond\n \nAE\n\n, \n\nShah\n \nBB\n\n, \n\nHuss\n \nDS\n\n, \n\n\n \nSafety and efficacy of focused ultrasound thalamotomy for patients with medication-refractory, tremor-dominant Parkinson disease: a randomized clinical trial\n. \nJAMA Neurol\n. \n2017\n;\n74\n(\n12\n):\n1412\n\u2013\n1418\n.\n10.1001\/jamaneurol.2017.309829084313"},{"issue":"5","key":"b8","series-title":"Mov Disord","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1002\/mds.27587","article-title":"Cost-effectiveness of magnetic resonance-guided focused ultrasound for essential tremor","volume":"34","author":"Li\n \nC","year":"2019","unstructured":"Li\n \nC\n\n, \n\nGajic-Veljanoski\n \nO\n\n, \n\nSchaink\n \nAK\n\n, \n\n\n \nCost-effectiveness of magnetic resonance-guided focused ultrasound for essential tremor\n. \nMov Disord\n. \n2019\n;\n34\n(\n5\n):\n735\n\u2013\n743\n.\n10.1002\/mds.2758730589951"},{"issue":"8","key":"b9","series-title":"Mov Disord","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1002\/mds.26997","article-title":"Cost-effectiveness of focused ultrasound, radiosurgery, and DBS for essential tremor","volume":"32","author":"Ravikumar\n \nVK","year":"2017","unstructured":"Ravikumar\n \nVK\n\n, \n\nParker\n \nJJ\n\n, \n\nHornbeck\n \nTS\n\n, \n\n\n \nCost-effectiveness of focused ultrasound, radiosurgery, and DBS for essential tremor\n. \nMov Disord\n. \n2017\n;\n32\n(\n8\n):\n1165\n\u2013\n1173\n.\n2837027210.1002\/mds.26997"},{"key":"b10","series-title":"Drug Alcohol Depend","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.drugalcdep.2017.02.002","article-title":"Repetitive transcranial magnetic stimulation (rTMS) of the dorsolateral prefrontal cortex reduces resting-state insula activity and modulates functional connectivity of the orbitofrontal cortex in cigarette smokers","volume":"174","author":"Li\n \nX","year":"2017","unstructured":"Li\n \nX\n\n, \n\nDu\n \nL\n\n, \n\nSahlem\n \nGL\n\n, \n\n\n \nRepetitive transcranial magnetic stimulation (rTMS) of the dorsolateral prefrontal cortex reduces resting-state insula activity and modulates functional connectivity of the orbitofrontal cortex in cigarette smokers\n. \nDrug Alcohol Depend\n. \n2017\n;\n174\n:\n98\n\u2013\n105\n.\n2831975510.1016\/j.drugalcdep.2017.02.002"},{"issue":"10","key":"b11","series-title":"JAMA Surg","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1001\/jamasurg.2014.292","article-title":"Effect of minimally invasive surgery on the risk for surgical site infections: results from the National Surgical Quality Improvement Program (NSQIP) database","volume":"149","author":"Gandaglia\n \nG","year":"2014","unstructured":"Gandaglia\n \nG\n\n, \n\nGhani\n \nKR\n\n, \n\nSood\n \nA\n\n, \n\n\n \nEffect of minimally invasive surgery on the risk for surgical site infections: results from the National Surgical Quality Improvement Program (NSQIP) database\n. \nJAMA Surg\n. \n2014\n;\n149\n(\n10\n):\n1039\n\u2013\n1044\n.\n10.1001\/jamasurg.2014.29225143176"},{"issue":"10","key":"b12","series-title":"Mov Disord","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1002\/mds.99","article-title":"Magnetic resonance-guided focused ultrasound thalamotomy for treatment of essential tremor: a 2-year outcome study","volume":"33","author":"Meng\n \nY","year":"2018","unstructured":"Meng\n \nY\n\n, \n\nSolomon\n \nB\n\n, \n\nBoutet\n \nA\n\n, \n\n\n \nMagnetic resonance-guided focused ultrasound thalamotomy for treatment of essential tremor: a 2-year outcome study\n. \nMov Disord\n. \n2018\n;\n33\n(\n10\n):\n1647\n\u2013\n1650\n.\n3028879410.1002\/mds.99"},{"issue":"5","key":"b13","series-title":"Mov Disord","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1002\/mds.27637","article-title":"Four-year follow-up results of magnetic resonance-guided focused ultrasound thalamotomy for essential tremor","volume":"34","author":"Park\n \nY-S","year":"2019","unstructured":"Park\n \nY-S\n\n, \n\nJung\n \nNY\n\n, \n\nNa\n \nYC\n\n, \n\nChang\n \nJW\n\n\n. \nFour-year follow-up results of magnetic resonance-guided focused ultrasound thalamotomy for essential tremor\n. \nMov Disord\n. \n2019\n;\n34\n(\n5\n):\n727\n\u2013\n734\n.\n10.1002\/mds.2763730759322"},{"key":"b14","series-title":"Parkinsonism Relat Disord","article-title":"Parkinson\u2019s disease motor subtype changes during 20 years of follow-up","author":"Eisinger\n \nRS","unstructured":"Eisinger\n \nRS\n\n, \n\nMartinez-Ramirez\n \nD\n\n, \n\nRamirez-Zamora\n \nA\n\n, \n\n\n \nParkinson\u2019s disease motor subtype changes during 20 years of follow-up\n. \nParkinsonism Relat Disord\n. \nPublished online May 19, 2019. doi:10.1016\/j.parkreldis.2019.05.024\n31129020"},{"issue":"36","key":"b15","series-title":"CMAJ","doi-asserted-by":"publisher","first-page":"E989","DOI":"10.1503\/cmaj.181504","article-title":"Canadian guideline for Parkinson disease","volume":"191","author":"Grimes\n \nD","year":"2019","unstructured":"Grimes\n \nD\n\n, \n\nFitzpatrick\n \nM\n\n, \n\nGordon\n \nJ\n\n, \n\n\n \nCanadian guideline for Parkinson disease\n. \nCMAJ\n. \n2019\n;\n191\n(\n36\n):\nE989\n\u2013\nE1004\n.\n10.1503\/cmaj.18150431501181"},{"issue":"1","key":"b16","series-title":"Lancet Neurol","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/S1474-4422(17)30403-9","article-title":"Focused ultrasound subthalamotomy in patients with asymmetric Parkinson\u2019s disease: a pilot study","volume":"17","author":"Mart\u00ednez-Fern\u00e1ndez\n \nR","year":"2018","unstructured":"Mart\u00ednez-Fern\u00e1ndez\n \nR\n\n, \n\nRodr\u00edguez-Rojas\n \nR\n\n, \n\nDel \u00c1lamo\n \nM\n\n, \n\n\n \nFocused ultrasound subthalamotomy in patients with asymmetric Parkinson\u2019s disease: a pilot study\n. \nLancet Neurol\n. \n2018\n;\n17\n(\n1\n):\n54\n\u2013\n63\n.\n2920315310.1016\/S1474-4422(17)30403-9"},{"issue":"6","key":"b17","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.3171\/2018.2.JNS172514","article-title":"The efficacy and limits of magnetic resonance-guided focused ultrasound pallidotomy for Parkinson\u2019s disease: a Phase I clinical trial","volume":"130","author":"Jung\n \nNY","year":"2019","unstructured":"Jung\n \nNY\n\n, \n\nPark\n \nCK\n\n, \n\nKim\n \nM\n\n, \n\n\n \nThe efficacy and limits of magnetic resonance-guided focused ultrasound pallidotomy for Parkinson\u2019s disease: a Phase I clinical trial\n. \nJ Neurosurg\n. \n2019\n;\n130\n(\n6\n):\n1853\n\u2013\n1861\n.\n10.3171\/2018.2.JNS172514"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/135\/1\/article-p273.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/135\/1\/article-p273.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/135\/1\/article-p273.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:55:38Z","timestamp":1792803338000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/135\/1\/article-p273.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":17,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3171\/2020.5.jns20692","relation":{},"ISSN":["0022-3085","1933-0693"],"issn-type":[{"value":"0022-3085","type":"print"},{"value":"1933-0693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8]]}}}